| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |